Skip to main content

Diagnostic options ยท UAE

Genetics tests in Dubai & UAE

Compare available Genetics tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

2,789

Listed price range

-1.00โ€“50,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Genetics test prices

Showing 2476โ€“2490 of 2,789 matching tests.

Genetics diagnostic tests, details, and listed prices
Test and description Specimen Typical duration Price Options
TEST-3377
SYCP3 Gene Sequencing (SPGF4) Test

This test identifies pathogenic variants in the SYCP3 gene associated with spermatogenic failure type 4 (SPGF4), a genetic cause of non-obstructive azoospermia in males.

Peripheral whole blood (EDTA tube) 21โ€“28 calendar days 2,800.00 AED
View
View test specifications and preparation
What it measures
["SYCP3 gene variants", "Pathogenic variants causing spermatogenic failure type 4"]
Parameters
[]
Preparation
["No fasting required", "Inform physician about anticoagulant medications"]
Indications
["Evaluation of male infertility", "Diagnosis of spermatogenic failure type 4 (SPGF4)"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81247-9 ICD-10: N46.0
Clinical summary
This test identifies pathogenic variants in the SYCP3 gene associated with spermatogenic failure type 4 (SPGF4), a genetic cause of non-obstructive azoospermia in males.
TEST-4379
SYN1 Gene Epilepsy Test (X-Linked, Genetic)

This test analyzes the SYN1 gene to identify mutations associated with X-linked epilepsy and related neurodevelopmental disorders.

Peripheral whole blood (EDTA), extracted DNA, or dried blood spot 3 to 4 Weeks from sample receipt 2,800.00 AED
View
View test specifications and preparation
What it measures
["SYN1 gene coding region variants", "SYN1 gene splice-site variants", "SYN1 gene copy-number variants"]
Parameters
[]
Preparation
["No specific fasting required", "No medication or diet restrictions"]
Indications
["Diagnosis of X-linked epilepsy", "Genetic counselling for families with X-linked neurodevelopmental disorders", "Cascade screening of at-risk relatives"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81247-9 ICD-10: G40.89, F70
Clinical summary
This test analyzes the SYN1 gene to identify mutations associated with X-linked epilepsy and related neurodevelopmental disorders.
TEST-4357
SYNE1 Gene Sequencing Test

This test identifies pathogenic variants in the SYNE1 gene, confirming a diagnosis of Emery-Dreifuss Muscular Dystrophy Type 4 (EDMD4).

Peripheral whole blood (EDTA tube) 3โ€“4 weeks including pre-test genetic counselling session 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the SYNE1 gene", "Coverage of all coding exons and splice sites"]
Parameters
[]
Preparation
["No fasting is required.", "Provide a detailed neurological and cardiac history.", "Attendance at the mandatory pre-test genetic counselling session is required."]
Indications
["Individuals presenting with early joint contractures", "Individuals with progressive muscle wasting", "Individuals with elevated creatine kinase levels", "Individuals with a family history suggestive of EDMD inheritance"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21636-6 ICD-10: G71.0
Clinical summary
This test identifies pathogenic variants in the SYNE1 gene, confirming a diagnosis of Emery-Dreifuss Muscular Dystrophy Type 4 (EDMD4).
TEST-4300
SYNE2 Gene Emery-Dreifuss Muscular Dystrophy Typeโ€ฏ5 Genetic Test

This genetic test identifies pathogenic variants in the SYNE2 gene associated with Emery-Dreifuss Muscular Dystrophy Type 5.

Whole Blood (Peripheral) 3 to 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the SYNE2 gene"]
Parameters
[]
Preparation
["No specific fasting required", "Inform lab of any relevant medications"]
Indications
["Confirm clinical suspicion of EDMD5", "Guide cardiac surveillance", "Inform family planning"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 88858-1 ICD-10: G71.0
Clinical summary
This genetic test identifies pathogenic variants in the SYNE2 gene associated with Emery-Dreifuss Muscular Dystrophy Type 5.
TEST-5599
SYNE4 Gene Deafness (Autosomal Recessive Type 76) Genetic Test

This genetic test identifies pathogenic variants in the SYNE4 gene associated with autosomal recessive hearing loss (DFNB76).

Peripheral whole blood, buccal swab, or FTA card 3 to 4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["SYNE4 gene variants", "Pathogenic mutations", "Likely pathogenic mutations"]
Parameters
[]
Preparation
["No fasting required", "No special preparation required"]
Indications
["Individuals with congenital or early-onset sensorineural hearing loss of unknown etiology", "Families with a history of autosomal recessive deafness", "Couples planning a family who are known carriers of a SYNE4 variant", "Individuals seeking clarification of a previous inconclusive genetic result", "Prenatal or preimplantation genetic testing in at-risk couples"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 101430-9 ICD-10: H90.3
Clinical summary
This genetic test identifies pathogenic variants in the SYNE4 gene associated with autosomal recessive hearing loss (DFNB76).
TEST-4945
SYNGAP1-Related Intellectual Disability (Autosomal Dominant Type 5) Genetic Test

This test identifies pathogenic variants in the SYNGAP1 gene, confirming a diagnosis of SYNGAP1-related intellectual disability.

Peripheral Whole Blood (EDTA), Extracted DNA, or Dried Blood Spot (FTA Card) 3โ€“4 weeks from sample receipt 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants (SNVs, indels) in the SYNGAP1 gene", "Copy number variants (via alternative methods, not this test)"]
Parameters
[]
Preparation
["Mandatory genetic counselling session before sample collection", "Inform phlebotomist if the child is on any anticoagulants"]
Indications
["Suspected SYNGAP1-related intellectual disability", "Evaluation of developmental delay and epilepsy", "Assessment of autism spectrum disorder with relevant family history"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 90396-6 ICD-10: F78.A
Clinical summary
This test identifies pathogenic variants in the SYNGAP1 gene, confirming a diagnosis of SYNGAP1-related intellectual disability.
TEST-5518
SYNJ1 Gene (PARK20) Parkinson Disease Genetic Test

This test identifies disease-causing mutations in the SYNJ1 gene associated with autosomal recessive juvenile-onset parkinsonism.

Peripheral Whole Blood (EDTA) 3โ€“4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the SYNJ1 gene", "Coding exons and flanking intronic regions"]
Parameters
[]
Preparation
["No specific fasting required", "Inform lab of all current medications"]
Indications
["Diagnosis of PARK20-linked parkinsonism", "Prognosis guidance", "Family planning"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 82939-0 ICD-10: G20
Clinical summary
This test identifies disease-causing mutations in the SYNJ1 gene associated with autosomal recessive juvenile-onset parkinsonism.
TEST-5063
SYP Gene X-Linked Intellectual Disability Type 96 Genetic Test

This test analyzes the SYP gene for pathogenic variants associated with X-linked intellectual disability type 96.

Whole Blood (3โ€“5 mL in EDTA), Extracted DNA, or FTA Card 3โ€“4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["SYP gene coding region", "SYP gene flanking splice sites"]
Parameters
[]
Preparation
[]
Indications
["Suspected X-linked intellectual disability type 96", "Family history of X-linked intellectual disability"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81305-3 ICD-10: F78
Clinical summary
This test analyzes the SYP gene for pathogenic variants associated with X-linked intellectual disability type 96.
TEST-1633
t(1;19)(q23;p13) E2A Fusion Qualitative Test

This test detects the presence or absence of the t(1;19)(q23;p13) E2A-PBX1 fusion transcript in a patient's sample.

Bone marrow aspirate or peripheral blood 3โ€“4 business days 600.00 AED
View
View test specifications and preparation
What it measures
["t(1;19)(q23;p13) E2A-PBX1 fusion transcript"]
Parameters
[]
Preparation
[]
Indications
["Diagnosis of B-cell acute lymphoblastic leukemia (B-ALL)", "Risk stratification in B-ALL", "Treatment guidance in B-ALL"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 48762-6 ICD-10: C91.00
Clinical summary
This test detects the presence or absence of the t(1;19)(q23;p13) E2A-PBX1 fusion transcript in a patient's sample.
TEST-3206
t(11;19)(q23;p13.3) MLL-ENL Fusion Qualitative PCR Test

This diagnostic test evaluates for the presence of the specific chromosomal translocation t(11;19)(q23;p13.3) resulting in the MLL-ENL fusion gene in leukemia patients.

Whole Blood (3 mL, EDTA Lavender Top) OR Bone Marrow Aspirate (EDTA tube) 3โ€“4 Working Days (Sample Mon/Thu by 11 AM; Report Wed/Sat) 650.00 AED
View
View test specifications and preparation
What it measures
["MLL-ENL fusion transcript", "Presence of t(11;19)(q23;p13.3) translocation"]
Parameters
[]
Preparation
["No fasting required", "Provide complete clinical history including prior chemotherapy, radiation, stem cell transplant dates, and current medications", "Bone marrow aspirate must be collected by a qualified hematologist in a clinical setting"]
Indications
["Diagnosis and classification of acute leukemia (AML, ALL, MLL)", "Prognostic assessment", "Guidance for therapy selection (e.g., menin inhibitors)", "Minimal residual disease (MRD) monitoring"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94055-8 ICD-10: C92.60, C92.62, Z15.09
Clinical summary
This diagnostic test evaluates for the presence of the specific chromosomal translocation t(11;19)(q23;p13.3) resulting in the MLL-ENL fusion gene in leukemia patients.
TEST-3211
t(9;11)(p21-22;q23) MLL-AF9 Fusion PCR Qualitative Test

This test detects the presence of the MLL-AF9 fusion transcript, a specific genetic marker associated with certain types of acute leukemia.

Bone marrow aspirate 3โ€“4 business days 650.00 AED
View
View test specifications and preparation
What it measures
["MLL-AF9 fusion transcript", "t(9;11)(p21-22;q23) chromosomal translocation"]
Parameters
[]
Preparation
["No fasting required", "Avoid anticoagulants if possible"]
Indications
["Diagnosis of AML/ALL", "Risk stratification in AML/ALL", "Minimal residual disease (MRD) monitoring in AML/ALL"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 60595-2 ICD-10: C92.0
Clinical summary
This test detects the presence of the MLL-AF9 fusion transcript, a specific genetic marker associated with certain types of acute leukemia.
TEST-3766
TAC3 Gene Hypogonadotropic Hypogonadism Type 10 Genetic Test

This test identifies pathogenic variants in the TAC3 gene, confirming the molecular basis for hypogonadotropic hypogonadism type 10.

Whole Blood (EDTA) 21โ€“28 calendar days 2,800.00 AED
View
View test specifications and preparation
What it measures
["TAC3 gene sequence", "Pathogenic variants (SNVs, indels, CNVs)"]
Parameters
[]
Preparation
["No specific fasting required", "Inform lab of any current hormonal therapy"]
Indications
["Suspected hypogonadotropic hypogonadism type 10", "Evaluation of delayed puberty or infertility", "Family history of hypogonadotropic hypogonadism"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21622-7 ICD-10: E23.0
Clinical summary
This test identifies pathogenic variants in the TAC3 gene, confirming the molecular basis for hypogonadotropic hypogonadism type 10.
TEST-5783
TALDO1 Gene Transaldolase Deficiency Genetic Test

This genetic test identifies mutations in the TALDO1 gene associated with transaldolase deficiency.

Whole Blood (EDTA), Extracted DNA, or Dried Blood Spot (FTA Card) 3โ€“4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the TALDO1 gene", "Single Nucleotide Variants (SNVs)", "Indels", "Exon-level Copy Number Variants (CNVs)"]
Parameters
[]
Preparation
["No fasting required", "Genetic counselling session required before sample submission"]
Indications
["Suspected transaldolase deficiency", "Family history of transaldolase deficiency", "Evaluation of inborn errors of metabolism"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81271-5 ICD-10: E74.89
Clinical summary
This genetic test identifies mutations in the TALDO1 gene associated with transaldolase deficiency.
TEST-5636
TANC1 Gene Psychomotor Retardation Genetic Test

This genetic test identifies pathogenic variants in the TANC1 gene, which are associated with autosomal dominant psychomotor retardation.

Whole blood, extracted DNA, or dried blood spot (FTA card) 3 โ€“ 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the TANC1 gene"]
Parameters
[]
Preparation
["No specific fasting required", "Inform phlebotomist of recent blood transfusions"]
Indications
["Suspected TANC1-related disorder", "Autosomal dominant psychomotor retardation"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 10213-6 ICD-10: Z13.71
Clinical summary
This genetic test identifies pathogenic variants in the TANC1 gene, which are associated with autosomal dominant psychomotor retardation.
TEST-2263
TANC2 Gene NGS Test for Brain Disorders

The TANC2 Gene NGS Test detects pathogenic variants in the TANC2 gene associated with neurodevelopmental disorders.

Peripheral whole blood or buccal swab 3โ€“4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the TANC2 gene", "Copy Number Variations (CNVs) in TANC2"]
Parameters
[]
Preparation
["No specific fasting required", "Inform lab of recent blood transfusions (within 2 weeks)"]
Indications
["Suspected TANC2-related neurodevelopmental disorder", "Family history of TANC2-related disorders", "Genetic counseling for neurodevelopmental conditions"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 95900-9 ICD-10: Q87.8, G93.89, Z15.89
Clinical summary
The TANC2 Gene NGS Test detects pathogenic variants in the TANC2 gene associated with neurodevelopmental disorders.

Category overview

Genetics: overview

Understanding your unique biological blueprint offers a profound sense of clarity and empowers proactive health planning for you and your family. At DNA Labs UAE, our specialized Genetics division employs state-of-the-art molecular technologies to provide deep insights into hereditary markers and cellular mutations. This comprehensive genetics testing in the UAE equips your healthcare provider with the precise data needed to tailor your medical guidance effectively. Recognized among top diagnostic labs in Dubai and the UAE, we prioritize your peace of mind through strict confidentiality protocols and exceptionally fast, accurate reporting. Take the next step in your health journey. View our genetics diagnostic services, book a private home collection, or consult our specialized team today.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area